Factors triggering abolishment of benzodiazepines effects in the four-plate test-retest in mice

European Neuropsychopharmacology

Volumn 18, Issue 1, 2008, Pages 41-47

  Petit Demouliere B ^a   Hascoet M ^a   Bourin, M ^a  

^a UNIVERSITÉ DE NANTES   (France)

Author keywords

Anxiety; Diazepam; DOI; Four plate test; One trial tolerance; Test retest

Indexed keywords

4 IODO 2,5 DIMETHOXYAMPHETAMINE; BENZODIAZEPINE DERIVATIVE; DIAZEPAM;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; ELECTROSTIMULATION; MALE; MAZE TEST; MOUSE; NONHUMAN; PRIORITY JOURNAL; TRANQUILIZING ACTIVITY; TREATMENT RESPONSE;

AMPHETAMINES; ANIMALS; ANTI-ANXIETY AGENTS; ANXIETY; AVOIDANCE LEARNING; DIAZEPAM; DRUG TOLERANCE; ELECTRIC STIMULATION; MALE; MICE; PUNISHMENT;

EID: 36749082419     PISSN: 0924977X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.euroneuro.2007.04.006     Document Type: Article

References (34)

1. Augustsson H., Dahlborn K., and Meyerson B.J. Exploration and risk assessment in female wild house mice (Mus musculus musculus) and two laboratory strains. Physiol. Behav. 84 (2005) 265-277
2. Bertoglio L.J., and Carobrez A.P. Anxiolytic effects of ethanol and phenobarbital are abolished in test-experienced rats submitted to the elevated plus maze. Pharmacol. Biochem. Behav. 73 (2002) 963-969
3. Blanchard D.C., Blanchard R.J., Tom P., and Rodgers R.J. Diazepam changes risk assessment in an anxiety/defense test battery. Psychopharmacology (Berl) 101 (1990) 511-518
4. Blanchard D.C., Blanchard R.J., and Rodgers R.J. Risk assessment and animal models of anxiety. In: Olivier B., Mos J., and Slangen J.L. (Eds). Animal Models in Psychopharmacology (1991), Birkhauser, Boston 117-234
5. Boissier J.R., Simon P., and Aron C. A new method for rapid screening of minor tranquillizers in mice. Eur. J. Pharmacol. 4 (1968) 145-151
6. Borsini F., Podhorna J., and Marazziti D. Do animal models of anxiety predict anxiolytic-like effects of antidepressants?. Psychopharmacology (Berl) 163 (2002) 121-141
7. Calzavara M.B., Patti C.L., Lopez G.B., Abilio V.C., Silva R.H., and Frussa-Filho R. Role of learning of open arm avoidance in the phenomenon of one-trial tolerance to the anxiolytic effect of chlordiazepoxide in mice. Life Sci. 76 (2005) 2235-2246
8. Crusio W.E. Genetic dissection of mouse exploratory behaviour. Behav. Brain Res. 125 (2001) 127-132
9. Cruz-Morales S.E., Santos N.R., and Brandao M.L. One-trial tolerance to midazolam is due to enhancement of fear and reduction of anxiolytic-sensitive behaviors in the elevated plus-maze retest in the rat. Pharmacol. Biochem. Behav. 72 (2002) 973-978
10. Dal-Col M.L., Pereira L.O., Rosa V.P., Calixto A.V., Carobrez A.P., and Faria M.S. Lack of midazolam-induced anxiolysis in the plus-maze Trial 2 is dependent on the length of Trial 1. Pharmacol. Biochem. Behav. 74 (2003) 395-400
11. Dawson G.R., Crawford S.P., Stanhope K.J., Iversen S.D., and Tricklebank M.D. One-trial tolerance to the effects of chlordiazepoxide on the elevated plus maze may be due to locomotor habituation, not repeated drug exposure. Psychopharmacology (Berl) 113 (1994) 570-572
12. Espejo E.F. Effects of weekly or daily exposure to the elevated plus-maze in male mice. Behav. Brain Res. 87 (1997) 233-238
13. File S.E. One-trial tolerance to the anxiolytic effects of chlordiazepoxide in the plus-maze. Psychopharmacology (Berl) 100 (1990) 281-282
14. File S.E., and Zangrossi Jr. H. "One-trial tolerance" to the anxiolytic actions of benzodiazepines in the elevated plus-maze, or the development of a phobic state?. Psychopharmacology (Berl) 110 (1993) 240-244
15. File S.E., Mabbutt P.S., and Hitchcott P.K. Characterisation of the phenomenon of "one-trial tolerance" to the anxiolytic effect of chlordiazepoxide in the elevated plus-maze. Psychopharmacology (Berl) 102 (1990) 98-101
16. File S.E., Andrews N., Wu P.Y., Zharkovsky A., and Zangrossi Jr. H. Modification of chlordiazepoxide's behavioural and neurochemical effects by handling and plus-maze experience. Eur. J. Pharmacol. 218 (1992) 9-14
17. File S.E., Zangrossi Jr. H., Viana M., and Graeff F.G. Trial 2 in the elevated plus-maze: a different form of fear?. Psychopharmacology (Berl) 111 (1993) 491-494
18. File S.E., Zangrossi Jr. H., Sanders F.L., and Mabbutt P.S. Raised corticosterone in the rat after exposure to the elevated plus-maze. Psychopharmacology (Berl) 113 (1994) 543-546
19. Frussa-Filho R., and Ribeiro Rde A. One-trial tolerance to the effects of chlordiazepoxide in the elevated plus-maze is not due to acquisition of a phobic avoidance of open arms during initial exposure. Life Sci. 71 (2002) 519-525
20. Hascoët M., Bourin M., and Couetoux du Tertre A. Influence of prior experience on mice behavior using the four-plate test. Pharmacol. Biochem. Behav. 58 (1997) 1131-1138
21. Holmes A., and Rodgers R.J. Responses of Swiss-Webster mice to repeated plus-maze experience: further evidence for a qualitative shift in emotional state?. Pharmacol. Biochem. Behav. 60 (1998) 473-488
22. Holmes A., and Rodgers R.J. Influence of spatial and temporal manipulations on the anxiolytic efficacy of chlordiazepoxide in mice previously exposed to the elevated plus-maze. Neurosci. Biobehav. Rev. 23 (1999) 971-980
23. Holmes A., Iles J.P., Mayell S.J., and Rodgers R.J. Prior test experience compromises the anxiolytic efficacy of chlordiazepoxide in the mouse light/dark exploration test. Behav. Brain Res. 122 (2001) 159-167
24. Lamprea M.R., Cardenas F.P., Silveira R., Morato S., and Walsh T.J. Dissociation of memory and anxiety in a repeated elevated plus maze paradigm: forebrain cholinergic mechanisms. Behav. Brain Res. 117 (2000) 97-105
25. Lister R.G. The use of a plus-maze to measure anxiety in the mouse. Psychopharmacology (Berl) 92 (1987) 180-185
26. Nic Dhonnchadha B.A., Bourin M., and Hascoet M. Anxiolytic-like effects of 5-HT2 ligands on three mouse models of anxiety. Behav. Brain Res. 140 (2003) 203-214
27. Pereira J.K., Vieira R.J., Konishi C.T., Ribeiro R.A., and Frussa-Filho R. The phenomenon of "one-trial tolerance" to the anxiolytic effect of chlordiazepoxide in the elevated plus-maze is abolished by the introduction of a motivational conflict situation. Life Sci. 65 (1999) PL101-PL107
28. Ripoll N., Nic Dhonnchadha B.A., Sebille V., Bourin M., and Hascoet M. The four-plates test-retest paradigm to discriminate anxiolytic effects. Psychopharmacology (Berl) 180 (2005) 73-83
29. Ripoll N., Hascoet M., and Bourin M. The four-plates test: anxiolytic or analgesic paradigm?. Prog. Neuro-Psychopharmacol. Biol. Psychiatry 30 (2006) 873-880
30. Rodgers R.J., Lee C., and Shepherd J.K. Effects of diazepam on behavioural and antinociceptive responses to the elevated plus-maze in male mice depend upon treatment regimen and prior maze experience. Psychopharmacology (Berl) 106 (1992) 102-110
31. Rodgers R.J., Johnson N.J., Cole J.C., Dewar C.V., Kidd G.R., and Kimpson P.H. Plus-maze retest profile in mice: importance of initial stages of trail 1 and response to post-trail cholinergic receptor blockade. Pharmacol. Biochem. Behav. 54 (1996) 41-50
32. Rodgers R.J., Johnson N.J., Carr J., and Hodgson T.P. Resistance of experientially-induced changes in murine plus-maze behaviour to altered retest conditions. Behav. Brain Res. 86 (1997) 71-77
33. Vargas K.M., Da Cunha C., and Andreatini R. Amphetamine and pentylenetetrazole given post-trial 1 enhance one-trial tolerance to the anxiolytic effect of diazepam in the elevated plus-maze in mice. Prog. Neuro-Psychopharmacol. Biol. Psychiatry 30 (2006) 1394-1402
34. Whimbey A.E., and Denenberg V.H. Two independent behavioral dimensions in open-field performance. J. Comp. Physiol. Psychol. 63 (1967) 500-504